The clinical impact of platelet refractoriness: correlation with bleeding and survival.
about
Transfusion medicine problems and solutions for the pediatric hematologist/oncologistIdentification of platelet refractoriness in oncohematologic patients.Romiplostim efficacy in an acute myeloid leukemia patient with transfusion refractory thrombocytopenia.Efficacy of HLA-matched platelet transfusions for patients with hypoproliferative thrombocytopenia: a systematic review.Utility of cross-matched platelet transfusions in patients with hypoproliferative thrombocytopenia: a systematic review.Extended Small-Dose Platelet Transfusions in Multitransfused Hemato-Oncological Patients: A Single-Center Experience.Platelet transfusions: trigger, dose, benefits, and risks.Detection and Identification of Platelet-Associated Alloantibodies by a Solid-Phase Modified Antigen Capture Elisa (MACE) Technique and Its Correlation to Platelet Refractoriness in Multi platelet Concentrate Transfused PatientsDetermination of an unrelated donor pool size for human leukocyte antigen-matched platelets in BrazilHLA alloimmunization against platelet transfusions: pathophysiology, significance, prevention and management.Resuscitating a dying marrow: the role of hematopoietic growth factors.Platelet refractoriness--practical approaches and ongoing dilemmas in patient management.Assessment of the Clinical Performance of Platelet Concentrates Treated by Pathogen Reduction Technology in Santiago de Compostela.The platelets' perspective to pathogen reduction technologies.Platelet transfusion refractoriness after T-cell-replete haploidentical transplantation is associated with inferior clinical outcomes.Measuring clinical bleeding using a standardized daily report form and a computer algorithm for adjudication of WHO bleeding grades.Storage-Induced Platelet Apoptosis Is a Potential Risk Factor for Alloimmunization Upon Platelet Transfusion.A future without human leukocyte antigens?
P2860
Q26851995-CED0DBC2-617A-42C0-9F4B-1CF002CD6DC3Q33394648-70B55466-BC53-4857-9D1F-794C23409612Q33398217-676BA081-F7E2-42F7-B574-7E8A04A73CF5Q33406794-500C98E7-CDA5-4A69-AE62-8E54D846E84BQ33410314-F2FC0116-CBFE-4D22-AEE0-36F1A9F7BBB4Q33441106-5737BAC1-9EF9-4F40-A8EF-21D306553ABDQ33870639-6DC18BED-802C-4ED6-85B6-1F61F0E88EBCQ34766786-BBFBD7AC-E41D-454F-94CD-3ECC0915B876Q36674849-FCC71857-BB26-45C9-A990-21B12AED732EQ37990036-7AA282F7-9219-41AF-B283-3B8089C3367EQ38259813-34D47D62-BA70-4257-AAEC-03C7CAB6BEB4Q38551094-7963AA48-32BC-45D8-BFBD-CA59E99DB77BQ38919548-B46329DD-3659-4692-9329-249F30D76B92Q40273685-15D3BFEF-E7D7-4053-B029-A1B967A85AAFQ50072576-1AC3A527-34D5-4602-995E-9B9A471B1872Q51242061-F9A01660-378C-4629-8563-C4B7224129F6Q55397497-2F90B5B7-3EF8-4AD5-BE84-62FD03B03AC1Q58124897-8B00C866-9093-4A91-8E38-0E386A29C2EE
P2860
The clinical impact of platelet refractoriness: correlation with bleeding and survival.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
The clinical impact of platelet refractoriness: correlation with bleeding and survival.
@ast
The clinical impact of platelet refractoriness: correlation with bleeding and survival.
@en
type
label
The clinical impact of platelet refractoriness: correlation with bleeding and survival.
@ast
The clinical impact of platelet refractoriness: correlation with bleeding and survival.
@en
prefLabel
The clinical impact of platelet refractoriness: correlation with bleeding and survival.
@ast
The clinical impact of platelet refractoriness: correlation with bleeding and survival.
@en
P2093
P1433
P1476
The clinical impact of platelet refractoriness: correlation with bleeding and survival.
@en
P2093
Anneke Brand
Jean-Louis H Kerkhoffs
Leo M G van de Watering
Pierre W Wijermans
Rinie J van Wordragen-Vlaswinkel
P304
P356
10.1111/J.1537-2995.2008.01799.X
P577
2008-06-28T00:00:00Z